Russian vaccine “Sputnik Light” was registered in Kazakhstan
On July 12, 2021, the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan (hereinafter referred to as the Committee) issued a temporary registration certificate for the Russian vaccine “Sputnik Light”.
“Sputnik Light” was registered on the basis of the minutes of the meeting of the Interdepartmental Commission on Preventing the Emergence and Spread of Coronavirus Infection in the Republic of Kazakhstan and the positive opinion of the National Center for Expertise of Medicines and Medical Devices in accordance with the Resolution of the Government of the Republic of Kazakhstan “On Approval of the Rules for Temporary State Registration of Vaccines against COVID Coronavirus -nineteen”.
The vaccine is registered in the country of the applicant’s manufacturer, and also meets the GMP requirements of the vaccine manufacturer’s production site.
The committee issued a temporary registration certificate for a period of 8 months.
Sputnik Light is a vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus, a solution for intramuscular administration. 0.5 ml / dose, manufactured in the Russian Federation.
The vaccine is the first component (recombinant human adenovirus 26 serotype (rAd26)) of the Sputnik V vaccine.
It should be noted that the Sputnik Light efficiency indicator is 79.4% from the 28th day after receiving immunization.
It should be emphasized that no serious adverse reactions were registered after immunization with Sputnik Light.
To date, this is the fifth vaccine approved for use in Kazakhstan.
Earlier, the list of vaccines used in the country included QazVac, Sputnik V, Hayat-Vax and CoronaVac.